Johnson & Johnson (JNJ): Price and Financial Metrics

JNJ POWR Grades

• Stability is the dimension where JNJ ranks best; there it ranks ahead of 94.84% of US stocks.
• JNJ's strongest trending metric is Momentum; it's been moving down over the last 52 weeks.
• JNJ's current lowest rank is in the Momentum metric (where it is better than 18.97% of US stocks).

JNJ Stock Summary

• Johnson & Johnson's market capitalization of $430,147,573,833 is ahead of 99.72% of US-listed equities.
• Johnson & Johnson's stock had its IPO on January 1, 1986, making it an older stock than 92.68% of US equities in our set.
• The volatility of Johnson & Johnson's share price is greater than that of just 0.68% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to Johnson & Johnson, a group of peers worth examining would be UNH, BAC, WMT, ADBE, and NFLX.
• JNJ's SEC filings can be seen here. And to visit Johnson & Johnson's official web site, go to www.jnj.com.

JNJ Valuation Summary

• JNJ's EV/EBIT ratio is 23.3; this is 20.48% lower than that of the median Healthcare stock.
• Over the past 243 months, JNJ's price/sales ratio has gone down 1.
• Over the past 243 months, JNJ's price/sales ratio has gone down 1.

Below are key valuation metrics over time for JNJ.

JNJ Growth Metrics

• The 5 year cash and equivalents growth rate now stands at 13.09%.
• Its year over year cash and equivalents growth rate is now at -18.41%.
• The 3 year net income to common stockholders growth rate now stands at -4.56%.

JNJ's revenue has moved up $16,659,000,000 over the prior 49 months.

The table below shows JNJ's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	89,190	26,114	17,767
2021-03-31	84,214	24,252	15,115
2020-12-31	82,584	23,536	14,714
2020-09-30	80,856	21,591	16,986
2020-06-30	80,503	20,735	15,185
2020-03-31	82,729	23,231	17,166

JNJ's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• JNJ has a Quality Grade of B, ranking ahead of 92.72% of graded US stocks.
• JNJ's asset turnover comes in at 0.514 -- ranking 81st of 681 Pharmaceutical Products stocks.
• ACRX, BCDA, and ABBV are the stocks whose asset turnover ratios are most correlated with JNJ.

The table below shows JNJ's key quality metrics over time.